Sodium Gluconate
FDA-approved product (injectable, injection).
- Registered studies
- 50+
- Lab records
- 0
- Pathogens at ≥40%
- 0 of 4
Chemical structure
Existing / approved use
Documented · FDA, WHO, ChEMBL- Anti-infective classification
- Neither a WHO ATC code nor an FDA pharmacologic class was found for it, so whether it is already an antimicrobial is not established. It needs review and is not counted as a repurposing candidate.
Repurposing investigation
No supported pathogen reaches ≥40% AI-predicted activity for Sodium Gluconate, so it is not among the repurposing candidates. Its predictions are shown below.
AI-predicted activity
AI prediction · nothing measured- MRSA10.3% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- E. coli23.0% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- K. pneumoniae11.4% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- M. tuberculosis18.4% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
A model’s estimate of laboratory activity against each pathogen species. It is not clinical effectiveness.
Evidence
Clinical and experimental
Documented evidenceClinical
50+registered studies name this medicine, for any condition. The registry search keeps the first 50, so there may be more. See them below.
Experimental
No evidence found
No laboratory measurement against the four pathogens in the ChEMBL records loaded here.
Docking
Computational · nothing measuredDihydrofolate reductase ↗ (E. coli)
Not yet docked: queued in the docking rundetails
KPC-2 carbapenemase ↗ (K. pneumoniae)
Not yet docked: queued in the docking rundetails
Enoyl-ACP reductase (InhA) ↗ (M. tuberculosis)
Not yet docked: queued in the docking rundetails
Dihydrofolate reductase ↗ (MRSA)
Not yet docked: queued in the docking rundetails
AutoDock Vina, one experimentally solved protein per pathogen. This project’s screening target is -7.0 kcal/mol, its own mark rather than a universal cutoff. A docking score is a structural hypothesis, not proof of binding, and requires experimental validation.
Other medicines to investigate
AI prediction · nothing measuredOther repurposing candidates: approved medicines besides Sodium Gluconate with AI-predicted activity ≥40% against the chosen pathogen, leaving out existing antimicrobials. They are computational candidates for further investigation, not alternatives and not recommendations.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- DactinomycinExisting use: Kidney Wilms tumor, Neoplasm95.6% AI-predicted activityagainst MRSALab records exist50+ registered studies
- TaurursodiolExisting use: Bile acids and derivatives79.6% AI-predicted activityagainst MRSA43 registered studies
- LinaclotideExisting use: Constipation, Constipation disorder, Irritable bowel syndrome74.5% AI-predicted activityagainst MRSA50+ registered studies
- PlecanatideExisting use: Constipation74.4% AI-predicted activityagainst MRSA15 registered studies
- OxytocinExisting use: Hemorrhage, Uterine Inertia74.2% AI-predicted activityagainst MRSA50+ registered studies
- PosaconazoleExisting use: Aspergillosis, Candidiasis, Coccidioidomycosis and 2 more72.2% AI-predicted activityagainst MRSA50+ registered studies
- SotorasibExisting use: Neoplasm, Non-small cell lung carcinoma70.6% AI-predicted activityagainst MRSA50+ registered studies
- TemsirolimusExisting use: Cancer, Clear cell renal carcinoma, Mantle cell lymphoma and 2 more70.1% AI-predicted activityagainst MRSA50+ registered studies
- Quizartinib DihydrochlorideExisting use: Acute myeloid leukemia, Myeloid leukemia70.0% AI-predicted activityagainst MRSA4 registered studies
- Irinotecan HydrochlorideExisting use: Adenocarcinoma, Cancer, Carcinoma and 4 more70.0% AI-predicted activityagainst MRSA50+ registered studies
- Deoxycholic AcidExisting use: Other dermatologicals69.3% AI-predicted activityagainst MRSA50+ registered studies
- ChenodiolExisting use: Cerebrotendinous xanthomatosis, Inborn errors of metabolism69.2% AI-predicted activityagainst MRSA30 registered studies
Registered studies
A registration describes a study; it does not establish a positive result.
Efficacy of Thread-Embedding Acupuncture Using the Longitudinal Oblique Technique From BL40 Toward BL57 on KOOS Scores and Joint Range of Motion in Knee Osteoarthritis
NCT07833462 · start 2026-09-23
Registered record
- Registry ID
- NCT07833462
- Conditions
- Knee Osteoarthritis
- Interventions
- Thread Embedding Acupuncture; Sham Thread Embedding Acupuncture
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Not yet recruiting
- Start
- 2026-09-23
- Completion
- 2026-11-25
- Enrolment
- 44
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionKnee OsteoarthritisInterventionThread Embedding Acupuncture; Sham Thread Embedding AcupuncturePhaseNot applicableRegistry statusNot yet recruitingCopper Supplementation in Cirrhosis
NCT07471542 · start 2026-03-15
Registered record
- Registry ID
- NCT07471542
- Conditions
- Cirrhosis; Chronic Liver Disease; Fibrosis; Infection
- Interventions
- Copper Gluconate
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Recruiting
- Start
- 2026-03-15
- Completion
- 2028-12
- Enrolment
- 30
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionCirrhosis; Chronic Liver Disease; Fibrosis; InfectionInterventionCopper GluconatePhaseNot applicableRegistry statusRecruitingEvaluation of the Anti-Plaque Effect of a Resveratrol-Based Mouthwash Using a 24-Hour Plaque Re-Growth
NCT07393802 · start 2026-03
Registered record
- Registry ID
- NCT07393802
- Conditions
- Mouthwash; Chlorhexidine; Biofilm Formation; Periodontal Health
- Interventions
- Resveratrol-Based Mouthwash; Chlorhexidine Gluconate 0.12 % Mouthwash; Placebo mouthwash
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Not yet recruiting
- Start
- 2026-03
- Completion
- 2026-05
- Enrolment
- 20
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMouthwash; Chlorhexidine; Biofilm Formation; Periodontal HealthInterventionResveratrol-Based Mouthwash; Chlorhexidine Gluconate 0.12 % Mouthwash; Placebo mouthwashPhasePhase 3Registry statusNot yet recruitingA Prospective, Single-arm, Trial to Determine Contamination Rates When Using an Antibacterial Incise Drape During Orthopedic Surgery
NCT07356323 · start 2026-02-19
Registered record
- Registry ID
- NCT07356323
- Conditions
- Arthroplasty Replacement, Knee; Arthroplasty Total Hip Replacement
- Interventions
- 3M™ Ioban™ CHG Chlorhexidine Gluconate Incise Drape (2% w/w CHG)
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Recruiting
- Start
- 2026-02-19
- Completion
- 2026-10
- Enrolment
- 179
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionArthroplasty Replacement, Knee; Arthroplasty Total Hip ReplacementIntervention3M™ Ioban™ CHG Chlorhexidine Gluconate Incise Drape (2% w/w CHG)PhaseNot applicableRegistry statusRecruitingEarly Intravenous Magnesium Sulfate and Its Impact on Cerebral Vasospasm in Traumatic Subarachnoid Hemorrhage
NCT07252505 · start 2025-11
Registered record
- Registry ID
- NCT07252505
- Conditions
- Trauma and Emergency Care
- Interventions
- Magnesium Sulfate 10 MG/ML
- Study type
- INTERVENTIONAL
- Phase
- Early phase 1
- Registry status
- Not yet recruiting
- Start
- 2025-11
- Completion
- 2027-10
- Enrolment
- 50
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionTrauma and Emergency CareInterventionMagnesium Sulfate 10 MG/MLPhaseEarly phase 1Registry statusNot yet recruitingESP vs. EXORA Blocks for Analgesia in Laparoscopic Cholecystectomy
NCT06900413 · start 2025-10-01
Registered record
- Registry ID
- NCT06900413
- Conditions
- Erector Spinae Plane Block; Laparoscopic Cholecystectomy; Plane Block
- Interventions
- Group ESP; Group EXORA
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2025-10-01
- Completion
- 2026-04-15
- Enrolment
- 56
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionErector Spinae Plane Block; Laparoscopic Cholecystectomy; Plane BlockInterventionGroup ESP; Group EXORAPhaseNot applicableRegistry statusCompletedA Stratified, Multi-ARm, muLti-site Randomised Platform Trial Aiming to Reduce the INcidence of Post-operative SSI
NCT06465901 · start 2024-09-01
Registered record
- Registry ID
- NCT06465901
- Conditions
- Surgical Site Infection
- Interventions
- Chlorhexidine Gluconate 2.0% to 4.0% (e.g. Hibiscrub) preoperative shower; Intraoperative wound wash (e.g. Granudacyn); DACC surgical wound dressing (e.g. Leukomed Sorbact)
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Not yet recruiting
- Start
- 2024-09-01
- Completion
- 2026-09-30
- Enrolment
- 10,092
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionSurgical Site InfectionInterventionChlorhexidine Gluconate 2.0% to 4.0% (e.g. Hibiscrub) preoperative shower; Intraoperative wound wash (e.g. Granudacyn); DACC surgical wound dressing (e.g. Leukomed Sorbact)PhaseNot applicableRegistry statusNot yet recruitingInvestigating the Effect of Chlorine Dioxide and Chlorhexidine Mouthwash on Bad Breath
NCT06219226 · start 2024-04-18
Registered record
- Registry ID
- NCT06219226
- Conditions
- Halitosis
- Interventions
- Chlorine dioxide mouthwash; Chlorhexidine mouthwash
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Enrolling by invitation
- Start
- 2024-04-18
- Completion
- 2025-12-18
- Enrolment
- 60
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHalitosisInterventionChlorine dioxide mouthwash; Chlorhexidine mouthwashPhaseNot applicableRegistry statusEnrolling by invitationThe Effect of Platelet-rich Plasma Nasal Injection in the Treatment of Traumatic Olfactory Dysfunction
NCT06290219 · start 2024-03-20
Registered record
- Registry ID
- NCT06290219
- Conditions
- Traumatic Olfactory Nerve Injury With Anosmia (Diagnosis); Effect of Drug
- Interventions
- platelet-rich plasma combined with hyaluronic acid; Zinc Gluconate 10 MG Oral Tablet; 4 bottles of phenyl ethyl alcohol, lemon, eucalyptus, and clove oil
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Unknown
- Start
- 2024-03-20
- Completion
- 2024-12-31
- Enrolment
- 80
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionTraumatic Olfactory Nerve Injury With Anosmia (Diagnosis); Effect of DrugInterventionplatelet-rich plasma combined with hyaluronic acid; Zinc Gluconate 10 MG Oral Tablet; 4 bottles of phenyl ethyl alcohol, lemon, eucalyptus, and clove oilPhasePhase 3Registry statusUnknownExplorative Study to Investigate the Acid-base Response to Sodium and Potassium Salts in Patients With Chronic Kidney Disease.
NCT06237712 · start 2024-01-26
Registered record
- Registry ID
- NCT06237712
- Conditions
- Metabolic Acidosis; CKD; Electrolyte and Fluid Balance Conditions
- Interventions
- Dietary supplement consisting of 40 mmol/daily of potassium chloride; Dietary supplement consisting of 40 mmol/daily of potassium gluconate; Dietary supplement consisting of 40 mmol/daily of potassium bicarbonate; Dietary supplement consisting of 40 mmol/daily of sodium chloride; Dietary supplement consisting of 40 mmol/daily of sodium bicarbonate; Placebo caps
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Active not recruiting
- Start
- 2024-01-26
- Completion
- 2026-07
- Enrolment
- 31
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMetabolic Acidosis; CKD; Electrolyte and Fluid Balance ConditionsInterventionDietary supplement consisting of 40 mmol/daily of potassium chloride; Dietary supplement consisting of 40 mmol/daily of potassium gluconate; Dietary supplement consisting of 40 mmol/daily of potassium bicarbonate; Dietary supplement consisting of 40 mmol/daily of sodium chloride +2 morePhaseNot applicableRegistry statusActive not recruitingSURGX Antimicrobial Gel Versus Povidone-iodine Skin Incision Prep in Total Shoulder Arthroplasty
NCT05919888 · start 2023-06-26
Registered record
- Registry ID
- NCT05919888
- Conditions
- Surgery; Surgical Site Infection; Cutibacterium Acnes; Prosthetic-joint Infection
- Interventions
- Povidone-Iodine; SURGX Wound Gel
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2023-06-26
- Completion
- 2023-11-14
- Enrolment
- 60
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionSurgery; Surgical Site Infection; Cutibacterium Acnes; Prosthetic-joint InfectionInterventionPovidone-Iodine; SURGX Wound GelPhasePhase 4Registry statusCompletedLactoferrin With Ferrous Gluconate Versus Ferrous Gluconate in Treatment of Iron Deficiency Anemia During Pregnancy
NCT06252103 · start 2023-05-30
Registered record
- Registry ID
- NCT06252103
- Conditions
- Lactoferrin With Ferrous Gluconate More Superior Than Ferrous Gluconate Alone in Treatment of Iron Deficiency Anemia
- Interventions
- Ferrous Gluconate 300 MG; ferrous gluconate with lactoferrin
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2023-05-30
- Completion
- 2023-12-30
- Enrolment
- 40
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionLactoferrin With Ferrous Gluconate More Superior Than Ferrous Gluconate Alone in Treatment of Iron Deficiency AnemiaInterventionFerrous Gluconate 300 MG; ferrous gluconate with lactoferrinPhasePhase 4Registry statusCompletedEffectiveness of Herbal vs Chlorhexidine Mouthwashes in Improving Oral Health in Schoolchildren
NCT07309679 · start 2023-03-07
Registered record
- Registry ID
- NCT07309679
- Conditions
- Plaque Score; Gingival Health; Streptococcus Mutans
- Interventions
- Chlorhexidine Digluconate 0.2% Mouthwash; Pomegranate Peel Extract Mouthwash; Neem Extract Mouthwash
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2023-03-07
- Completion
- 2023-11-07
- Enrolment
- 156
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPlaque Score; Gingival Health; Streptococcus MutansInterventionChlorhexidine Digluconate 0.2% Mouthwash; Pomegranate Peel Extract Mouthwash; Neem Extract MouthwashPhaseNot applicableRegistry statusCompletedZinc Deficiency Treatment in Celiac Disease: Supplementation Versus Diet
NCT05782257 · start 2022-12-08
Registered record
- Registry ID
- NCT05782257
- Conditions
- Celiac Disease; Nutrient Deficiency
- Interventions
- Zinc Supplementation; Zn-Optimized Diet
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Unknown
- Start
- 2022-12-08
- Completion
- 2024-09-01
- Enrolment
- 50
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionCeliac Disease; Nutrient DeficiencyInterventionZinc Supplementation; Zn-Optimized DietPhaseNot applicableRegistry statusUnknownEvaluation of Collagen-based Medical Device Treatment Combined With Physiotherapy in Subjects With Achilles Tendinopathy.
NCT05464498 · start 2022-06-13
Registered record
- Registry ID
- NCT05464498
- Conditions
- Tendinopathy; Insertional Achilles Tendinopathy; Achilles Tendinopathy; Peritendinitis
- Interventions
- MD-Tissue Collagen Medical Device; eccentric strengthening protocol
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Recruiting
- Start
- 2022-06-13
- Completion
- 2026-11-01
- Enrolment
- 72
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionTendinopathy; Insertional Achilles Tendinopathy; Achilles Tendinopathy; PeritendinitisInterventionMD-Tissue Collagen Medical Device; eccentric strengthening protocolPhaseNot applicableRegistry statusRecruiting